CRLconf 0.97

adx-2191 — CRL

$ALDX · Aldeyra Therapeutics, Inc. · primary vitreoretinal lymphoma

Event date

June 21, 2023

1081 days ago

Sponsor runway

38 mo

$65.0M liquid

Evidence

“the Company received a Complete Response Letter from the FDA for the 505(b)(2) New Drug Application of ADX-2191 (methotrexate for injection, USP) for the treatment of primary vitreoretinal lymphoma”

Source: 8-K filed 2023-06-21View on EDGAR ↗0001157523-23-001018

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

7 insiders · 1 buys · 0 sells

Exercise

2023-09-07

Phillips Gary M.

Director

5,437 @ $0.55$3K

Tax

2023-09-07

Brady Todd C

President and CEO

73,807 @ $7.22$533K

Exercise

2023-09-07

Brady Todd C

President and CEO

192,084 @ $0.55$106K

Exercise

2023-09-07

Brady Todd C

President and CEO

32,953 @ $0.55$18K

Exercise

2023-09-07

Brady Todd C

President and CEO

48,021 @ $0.55$27K

Exercise

2023-08-22

Walker Neal

Director

9,604 @ $0.55$5K

Grant

2023-06-30

Bronstein Ben

Director

21,222 @ ——

Grant

2023-06-30

Bronstein Ben

Director

1,372 @ ——

Grant

2023-06-30

Bronstein Ben

Director

1,464 @ ——

Grant

2023-06-30

Walker Neal

Director

21,222 @ ——

Grant

2023-06-30

Walker Neal

Director

915 @ ——

Grant

2023-06-30

DOUGLAS RICHARD

Director

21,222 @ ——

Grant

2023-06-30

DOUGLAS RICHARD

Director

5,488 @ ——

Grant

2023-06-30

DOUGLAS RICHARD

Director

640 @ ——

Grant

2023-06-30

JOYCE MARTIN JOSEPH

Director

21,222 @ ——

Grant

2023-06-30

JOYCE MARTIN JOSEPH

Director

640 @ ——

Grant

2023-06-30

JOYCE MARTIN JOSEPH

Director

2,744 @ ——

Grant

2023-06-30

Phillips Gary M.

Director

21,222 @ ——

Grant

2023-06-30

Phillips Gary M.

Director

1,829 @ ——

Grant

2023-06-30

Phillips Gary M.

Director

1,372 @ ——

Grant

2023-06-30

Miller-Rich Nancy

Director

21,222 @ ——

Grant

2023-06-30

Miller-Rich Nancy

Director

915 @ ——

Exercise

2023-06-27

Bronstein Ben

Director

9,604 @ $0.55$5K

Buy

2023-04-12

Miller-Rich Nancy

Director

509 @ $10.13$5K

Date	Insider	Action	Shares	Price	Value
2023-09-07	Phillips Gary M.Director	Exercise	5,437	$0.55	$3K
2023-09-07	Brady Todd CPresident and CEO	Tax	73,807	$7.22	$533K
2023-09-07	Brady Todd CPresident and CEO	Exercise	192,084	$0.55	$106K
2023-09-07	Brady Todd CPresident and CEO	Exercise	32,953	$0.55	$18K
2023-09-07	Brady Todd CPresident and CEO	Exercise	48,021	$0.55	$27K
2023-08-22	Walker NealDirector	Exercise	9,604	$0.55	$5K
2023-06-30	Bronstein BenDirector	Grant	21,222	—	—
2023-06-30	Bronstein BenDirector	Grant	1,372	—	—
2023-06-30	Bronstein BenDirector	Grant	1,464	—	—
2023-06-30	Walker NealDirector	Grant	21,222	—	—
2023-06-30	Walker NealDirector	Grant	915	—	—
2023-06-30	DOUGLAS RICHARDDirector	Grant	21,222	—	—
2023-06-30	DOUGLAS RICHARDDirector	Grant	5,488	—	—
2023-06-30	DOUGLAS RICHARDDirector	Grant	640	—	—
2023-06-30	JOYCE MARTIN JOSEPHDirector	Grant	21,222	—	—
2023-06-30	JOYCE MARTIN JOSEPHDirector	Grant	640	—	—
2023-06-30	JOYCE MARTIN JOSEPHDirector	Grant	2,744	—	—
2023-06-30	Phillips Gary M.Director	Grant	21,222	—	—
2023-06-30	Phillips Gary M.Director	Grant	1,829	—	—
2023-06-30	Phillips Gary M.Director	Grant	1,372	—	—
2023-06-30	Miller-Rich NancyDirector	Grant	21,222	—	—
2023-06-30	Miller-Rich NancyDirector	Grant	915	—	—
2023-06-27	Bronstein BenDirector	Exercise	9,604	$0.55	$5K
2023-04-12	Miller-Rich NancyDirector	Buy	509	$10.13	$5K

← All catalysts for $ALDX